Cytomx analysts
WebApr 14, 2024 · CytomX Therapeutics, Inc. (NASDAQ:CTMX – Get Rating) has received an average rating of “Hold” from the twelve analysts that are covering the firm, Marketbeat … WebCytomX Therapeutics Stock (NASDAQ:CTMX), Analyst Ratings, Price Targets, Predictions. Analysts publish ratings and price targets on most stocks. Benzinga tracks …
Cytomx analysts
Did you know?
WebJan 6, 2024 · January 6, 2024, 1:46 PM · 3 min read Shares of CytomX Therapeutics CTMX were up 55.3% in after-market trading on Jan 5 after management announced its collaboration agreement with Moderna … WebApr 13, 2024 · This is a summary of recent ratings and recommmendations for CytomX Therapeutics and Stoke Therapeutics, as provided by MarketBeat. CytomX Therapeutics currently has a consensus price target of $3.17, indicating a potential upside of 94.57%. Stoke Therapeutics has a consensus price target of $24.57, indicating a potential upside …
WebMar 20, 2024 · CytomX Therapeutics Price Performance. Shares of NASDAQ:CTMX opened at $1.86 on Monday. The company has a market capitalization of $122.91 million, a price-to-earnings ratio of -1.25 and a beta of ... WebMar 2, 2024 · InvestorsObserveris giving CytomX Therapeutics Inc (CTMX) an Analyst Rating Rank of 15, meaning CTMX is ranked higher by analysts than 15% of stocks. The average price target for CTMX is $3.564 and analyst’s rate the stock as a Buy. Wall Street analysts are rating CTMX a Buy today.
WebGlassdoor gives you an inside look at what it's like to work at CytomX Therapeutics, including salaries, reviews, office photos, and more. This is the CytomX Therapeutics … WebApr 14, 2024 · CytomX Therapeutics, Inc. ( NASDAQ:CTMX – Get Rating) has been assigned a consensus recommendation of “Hold” from the twelve analysts that are …
WebApr 6, 2024 · Find the latest CytomX Therapeutics, Inc. (CTMX) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears.
WebWhat are analysts forecasts for CytomX stock? The 16 analysts offering price forecasts for CytomX have a median target of 6.42, with a high estimate of 16.00 and a low estimate … new straitsWebApr 14, 2024 · CytomX Therapeutics, Inc. (NASDAQ:CTMX – Get Rating) has been assigned a consensus recommendation of “Hold” from the twelve analysts that are presently covering the stock, Marketbeat reports. midnight buffet deals in hyderabadWebCTMX Stock 12 Months Forecast. Based on 4 Wall Street analysts offering 12 month price targets for CytomX Therapeutics in the last 3 months. The average price target is $2.48 … midnight bud gatechWebAnalyst Coverage. CytomX Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding CytomX Therapeutics, … Annual Reports - Analyst Coverage CytomX Therapeutics, Inc. PD-1 Probody™ Therapeutic Anti-tumor Efficacy and Protection Against … CytomX Therapeutics, Inc. 151 Oyster Point Blvd Suite 400 South San Francisco, CA … Mr. Ogden joined CytomX in August of 2024 after a 16-year tenure at Eli Lilly and … SOUTH SAN FRANCISCO, Calif. , March 22, 2024 (GLOBE NEWSWIRE) -- … Stock Information - Analyst Coverage CytomX Therapeutics, Inc. Events and Presentations - Analyst Coverage CytomX Therapeutics, Inc. midnight brownies made with black beansWebCytomX Therapeutics, Inc. Analyst Report: AbbVie Inc AbbVie, a research-based biopharmaceutical company, was spun off from Abbott Laboratories in January 2013. … new strand of omicronWebApr 6, 2024 · CytomX Therapeutics is a smaller company with a market capitalization of US$181m, so it may still be flying under the radar of many institutional investors. In the chart below, we can see that... midnight buffet in bangaloreWebBuild your future. DXC is where brilliant people embrace change and seize opportunities to advance their careers and amplify customer success. 240+. customers in the. Fortune … new strand of covid name